DUBLIN–()–The “Regulatory Report: Changes Expected to France’s Regulation of CBD” report has been added to ResearchAndMarkets.com’s offering.

Regulation, and the interpretation of existing rules, of cannabis in all its forms is a recurring subject in France, and one that is set to continue following the Court of Justice of the European Union (CJEU)’s recent decision in the Kanavape case. Aside from changes relating to that, there are a number of other proposals relating to France’s medical cannabis regime. This report provides a detailed overview of all current and possible future regulation.

The CJEU’s recent ruling is likely to have deep consequences for Europe’s CBD industry, and while France has not released an interpretation yet, the government will have no…

Read Full Article Here